4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine

C123H131N31O12 — CID 163965480

IUPAC4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine
SMILESCc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OCCc4ccnn4C)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OCCc4cnn(C)c4)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OC[C@@H](O)c4ccccc4)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OC[C@H](O)c4ccccc4)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OCc4cccnn4)n3)n2)c1
InChIInChI=1S/2C26H27N5O3.2C24H27N7O2.C23H23N7O2/c2*1-19-6-5-9-21(16-19)22-10-11-31(29-22)25-17-24(30-12-14-33-15-13-30)27-26(28-25)34-18-23(32)20-7-3-2-4-8-20;1-18-4-3-5-19(16-18)21-7-10-31(28-21)23-17-22(30-11-14-32-15-12-30)26-24(27-23)33-13-8-20-6-9-25-29(20)2;1-18-4-3-5-20(14-18)21-6-8-31(28-21)23-15-22(30-9-12-32-13-10-30)26-24(27-23)33-11-7-19-16-25-29(2)17-19;1-17-4-2-5-18(14-17)20-7-9-30(28-20)22-15-21(29-10-12-31-13-11-29)25-23(26-22)32-16-19-6-3-8-24-27-19/h2*2-11,16-17,23,32H,12-15,18H2,1H3;3-7,9-10,16-17H,8,11-15H2,1-2H3;3-6,8,14-17H,7,9-13H2,1-2H3;2-9,14-15H,10-13,16H2,1H3/t2*23-;;;/m10.../s1
InChIKeySLIHVQRMDGNKOU-FBKXPWLNSA-N
MW2235.61 g/mol
LogP15.68
Rot. Bonds34

About 4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine

4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine (PubChem CID 163965480) has the molecular formula C123H131N31O12 and a molecular weight of 2235.61 g/mol. Its IUPAC name is 4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine.

Molecular Properties

Compound Name4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine
PubChem CID163965480
Molecular FormulaC123H131N31O12
Molecular Weight2235.61 g/mol
Exact Mass2234.06
IUPAC Name4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine
SMILESCc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OCCc4ccnn4C)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OCCc4cnn(C)c4)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OC[C@@H](O)c4ccccc4)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OC[C@H](O)c4ccccc4)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OCc4cccnn4)n3)n2)c1
InChIInChI=1S/2C26H27N5O3.2C24H27N7O2.C23H23N7O2/c2*1-19-6-5-9-21(16-19)22-10-11-31(29-22)25-17-24(30-12-14-33-15-13-30)27-26(28-25)34-18-23(32)20-7-3-2-4-8-20;1-18-4-3-5-19(16-18)21-7-10-31(28-21)23-17-22(30-11-14-32-15-12-30)26-24(27-23)33-13-8-20-6-9-25-29(20)2;1-18-4-3-5-20(14-18)21-6-8-31(28-21)23-15-22(30-9-12-32-13-10-30)26-24(27-23)33-11-7-19-16-25-29(2)17-19;1-17-4-2-5-18(14-17)20-7-9-30(28-20)22-15-21(29-10-12-31-13-11-29)25-23(26-22)32-16-19-6-3-8-24-27-19/h2*2-11,16-17,23,32H,12-15,18H2,1H3;3-7,9-10,16-17H,8,11-15H2,1-2H3;3-6,8,14-17H,7,9-13H2,1-2H3;2-9,14-15H,10-13,16H2,1H3/t2*23-;;;/m10.../s1
InChIKeySLIHVQRMDGNKOU-FBKXPWLNSA-N
XLogP15.68
TPSA428.38 Ų
H-Bond Donors2
H-Bond Acceptors43
Rotatable Bonds34
Heavy Atoms166
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002235.61
LogP ≤ 515.68
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1043

Analyze 4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine?
The IUPAC name of 4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine (CID 163965480) is 4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine.
What is the SMILES notation for 4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine?
The canonical SMILES for 4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine is Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OCCc4ccnn4C)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OCCc4cnn(C)c4)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OC[C@@H](O)c4ccccc4)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OC[C@H](O)c4ccccc4)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OCc4cccnn4)n3)n2)c1.
What is the InChIKey of 4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine?
The InChIKey is SLIHVQRMDGNKOU-FBKXPWLNSA-N. The full InChI is InChI=1S/2C26H27N5O3.2C24H27N7O2.C23H23N7O2/c2*1-19-6-5-9-21(16-19)22-10-11-31(29-22)25-17-24(30-12-14-33-15-13-30)27-26(28-25)34-18-23(32)20-7-3-2-4-8-20;1-18-4-3-5-19(16-18)21-7-10-31(28-21)23-17-22(30-11-14-32-15-12-30)26-24(27-23)33-13-8-20-6-9-25-29(20)2;1-18-4-3-5-20(14-18)21-6-8-31(28-21)23-15-22(30-9-12-32-13-10-30)26-24(27-23)33-11-7-19-16-25-29(2)17-19;1-17-4-2-5-18(14-17)20-7-9-30(28-20)22-15-21(29-10-12-31-13-11-29)25-23(26-22)32-16-19-6-3-8-24-27-19/h2*2-11,16-17,23,32H,12-15,18H2,1H3;3-7,9-10,16-17H,8,11-15H2,1-2H3;3-6,8,14-17H,7,9-13H2,1-2H3;2-9,14-15H,10-13,16H2,1H3/t2*23-;;;/m10.../s1.
What are the key properties of 4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine?
4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine has a molecular weight of 2235.61 g/mol, XLogP of 15.68, 34 rotatable bonds, 2 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine is sourced from PubChem (CID 163965480), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).